JBT Marel (JBTM) Q1 2026 earnings review
Merger Execution Pays Off, But Segments Diverge Sharply
JBT Marel's first quarter of 2026 proves the financial logic of the merger is working. The company posted its second consecutive quarter of >$1 billion in inbound orders, with Adjusted EPS surging to $1.58 from $0.97 a year ago. The balance sheet is improving at an Accelerating pace, with leverage dropping to 2.6x. However, beneath the consolidated success lies a tale of two vastly different businesses: Protein Solutions is firing on all cylinders with 22% growth and massive margin expansion, while Prepared Food and Beverage (PF&B) is completely Stable on the top line (0% growth) but Decelerating on the bottom line due to CPG market weakness, warehouse automation struggles, and tariff headwinds.
🐂 Bull Case
Protein Solutions grew revenue by 22% (8% FX benefit) and expanded adjusted EBITDA margin by an impressive 500 basis points to 21.7%. Poultry demand is driving massive operating leverage.
Free cash flow of $100M in a seasonally lighter Q1 allowed the company to cut net debt leverage to 2.6x, well ahead of historical integration timelines, significantly de-risking the balance sheet.
🐻 Bear Case
The PF&B segment is a major drag. Zero revenue growth combined with a 170 basis point drop in adjusted EBITDA margin highlights deep execution and end-market issues.
Tariffs remain a structural reality. Management reiterated a 25-50 basis point net negative impact for the full year 2026, meaning pricing power is not fully offsetting geopolitical friction.
⚖️ Verdict: 🟢
Bullish. While the PF&B segment is a legitimate concern, the sheer cash generation, order momentum, and margin expansion in Protein Solutions validate the underlying investment thesis. Debt reduction provides a substantial margin of safety.
Key Themes
Protein Solutions Accelerating
The Protein segment is the unquestioned star. Revenue grew 22% YoY to $460M, and operating leverage pushed the segment's Adjusted EBITDA margin to an exceptional 21.7% (up >500 bps YoY). Management cited higher poultry volume and continued improvements in the meat and fish businesses as the primary catalysts.
Prepared Food & Beverage Lagging Substantially
In stark contrast to Protein, the PF&B segment is Reversing its margin progress. Revenue was flat at $476M (even with a 4% FX benefit, meaning organic growth was negative). Segment Adjusted EBITDA margin contracted 170 basis points YoY to 14.7%. This contradicts the consolidated margin expansion narrative and isolates the company's weak spots.
CPG End-Market Volume Weakness
Management explicitly blamed 'lower volume from the CPG end market' as a key driver for the PF&B segment's margin compression. This macro reality indicates that while agricultural processing (poultry/meat) is flush with cash, downstream consumer packaged goods customers are tightening capital expenditures.
Order Momentum Remains Above $1 Billion
Total orders reached $1.07 billion (inclusive of $60M FX benefit). This marks the second consecutive quarter above the $1 billion threshold, resulting in a book-to-bill ratio of 1.14x. The total backlog remains highly Stable at $1.49 billion, locking in future revenue visibility.
Rapid Deleveraging via Strong Free Cash Flow
The company generated $119M in operating cash flow and $100M in free cash flow in Q1. This cash generation, coupled with EBITDA growth, allowed Net Debt to TTM Adjusted EBITDA to drop to 2.6x. This rapid deleveraging vastly reduces interest expense and financial risk compared to a year ago when the Marel transaction was just closing.
Tariff Costs and Warehouse Automation Struggles
Tariffs remain a stubborn headwind, with management reiterating an expected 25 to 50 basis point net negative impact on full-year 2026 margins. Additionally, management cited ongoing 'operational challenges in the warehouse automation business' (AGVs), suggesting problems highlighted in mid-2025 have not yet been fixed.
NextGen Strategy Introduced
At the 2026 Investor Day, the company transitioned from integration talk to its 'NextGen strategy.' Key pillars include a customer-centric service model, targeted innovation to enhance full-line product offerings, and cross-selling. The shift in narrative indicates that basic M&A plumbing is complete, and the focus is now strictly on commercial execution.
Other KPIs
A massive Reversing trend from a devastating loss in Q1 2025 (which was bogged down by $147M in pension settlements and massive M&A fees). Net income improved by $218M YoY to $45M, proving the company has successfully digested the Marel acquisition and returned to clean, structural profitability.
Accelerating significantly from $0.97 in the prior year. The 63% YoY increase reflects not just operational margin expansion, but the mathematical benefit of lower interest expense as the company aggressively pays down its debt load.
Guidance
Stable. The company reiterated its guidance of 5% to 7% YoY growth (inclusive of ~1% FX benefit). Given the $1.07B in orders this quarter, this target appears conservative and highly achievable.
Accelerating compared to the 15.2% delivered in Q1 2026. This implies the company expects profitability to ramp up significantly in the back half of the year, relying heavily on the $60M in expected realized synergy cost savings.
Reiterated. At the midpoint, this implies robust double-digit earnings growth YoY. The company explicitly noted that this excludes approximately $178M in acquisition-related amortization, keeping the "adjusted" metric clean for operations.
Key Questions
Path to PF&B Recovery
Given the 170 basis point margin contraction and flat revenue in the Prepared Food & Beverage segment, what specific actions are being taken to stabilize the warehouse automation business, and when do you expect this segment to return to margin expansion?
CPG End-Market Dynamics
You cited lower volume from the CPG end market. Are these project delays, or permanent cancellations? How much visibility do you have into CPG CapEx budgets for the second half of 2026?
Tariff Mitigation Strategy
You reiterated a 25 to 50 basis point net impact from tariffs for 2026. Given the aggressive supply chain regionalization you discussed in late 2025, why aren't these mitigation efforts fully neutralizing the tariff penalty yet?
Capital Allocation with Lower Leverage
With net leverage already down to 2.6x, you are well within your targeted 2.0x-2.5x range. Does capital allocation now pivot toward share repurchases, or are there new bolt-on M&A targets on the horizon?